Indore SEZ exports jump 32 pc due to increased orders from pharma units

Exports from Indore’s Special Economic Zone (SEZ) jumped 32 percent to Rs 8,127.67 crore during the first seven months of the current financial year due to increased orders from pharmaceutical units, an official said on Monday.

According to an official from the Union Ministry of Commerce and Industry, the Indore SEZ, which houses factories manufacturing various products, exported Rs 8,127.67 crore from April-October in the current financial year.

He said in the previous financial year, exports from this SEZ from April to October were worth Rs 6,157.11 crore.

“About 70 percent of exports from the Indore SEZ are pharmaceuticals, and the United States is among the top importers of these drugs,” the official said.

He said the Indore SEZ, spread over 572 hectares in the Pithampur Industrial Area, houses 59 plants in various sectors, including pharmaceuticals, packaging materials, engineering, textile manufacturing, and food processing. Of these, 22 are in the pharmaceutical sector alone.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg